Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-31, Stock:ABT, The news for the past five days is as follows:
2018-07-24: NEWS1: ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors.NEWS2: Houston medical device startup hires former Abbott exec as CEO.NEWS3: What Drove Growth for J&J’s Medical Device Business?.
2018-07-25: NEWS1: JNJ Stock Rose on Strong Q2 Results: Will Momentum Continue?.
2018-07-26: NEWS1: Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease.NEWS2: See what the IHS Markit Score report has to say about Abbott Laboratories..
2018-07-27: NEWS1: Wichita hospital selected for medical device clinical trial.NEWS2: Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S..NEWS3: Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2.NEWS4: Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2.NEWS5: Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss.NEWS6: Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss.NEWS7: ABT’s Q2 2018 EPS Beat Analysts’ Estimates and Company Guidance.NEWS8: Abbott Laboratories: Solid Sales in Its Business Segments in Q2.NEWS9: Wall Street Raises Target Price on ABT after Strong Q2 Earnings.NEWS10: Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss.NEWS11: Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2.NEWS12: EW Fell 5.8% in After-Hours Trading despite Strong Q2 Results.NEWS13: Pharma Favorites: 7 Healthy Picks in the Drug Sector.
2018-07-30: NEWS1: Abbott Laboratories’ Nutrition Sales Recovered in Q2 2018.NEWS2: ABT Saw 12.3% Growth in Established Pharmaceuticals Segment.NEWS3: How ABT’s Diagnostics Business Performed in Q2 2018.

Answer: Rise